Suppr超能文献

增殖性糖尿病视网膜病变患者眼玻璃体内血管内皮生长因子水平升高。

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

作者信息

Adamis A P, Miller J W, Bernal M T, D'Amico D J, Folkman J, Yeo T K, Yeo K T

机构信息

Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston 02114.

出版信息

Am J Ophthalmol. 1994 Oct 15;118(4):445-50. doi: 10.1016/s0002-9394(14)75794-0.

Abstract

The vitreous levels of the angiogenic polypeptide vascular endothelial growth factor (also known as vascular permeability factor) were measured and compared in eyes with and without proliferative diabetic retinopathy. Undiluted vitreous samples from 20 eyes were collected at the time of vitrectomy, and vascular endothelial growth factor levels were determined by using a time-resolved immunofluorometric assay. Vitreous vascular endothelial growth factor levels were significantly higher in eyes with proliferative diabetic retinopathy than in eyes without proliferative diabetic retinopathy (P = .006; Wilcoxon Rank Sum Test). The median vitreous concentration in the eyes with proliferative diabetic retinopathy was 29.1 pM and exceeded the known concentration required for the maximal proliferation of vascular endothelial cells in vitro. These data are consistent with vascular endothelial growth factor serving as a physiologically relevant angiogenic factor in proliferative diabetic retinopathy.

摘要

对患有和未患有增殖性糖尿病视网膜病变的眼睛,测量并比较血管生成多肽血管内皮生长因子(也称为血管通透性因子)的玻璃体水平。在玻璃体切割术时收集20只眼睛的未稀释玻璃体样本,并使用时间分辨免疫荧光分析法测定血管内皮生长因子水平。增殖性糖尿病视网膜病变患者眼睛的玻璃体血管内皮生长因子水平显著高于无增殖性糖尿病视网膜病变的眼睛(P = 0.006;Wilcoxon秩和检验)。增殖性糖尿病视网膜病变患者眼睛的玻璃体中位浓度为29.1 pM,超过了体外血管内皮细胞最大增殖所需的已知浓度。这些数据与血管内皮生长因子作为增殖性糖尿病视网膜病变中生理相关血管生成因子的作用一致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验